Literature DB >> 31267381

LncRNA differentiation antagonizing non-protein coding RNA promotes proliferation and invasion through regulating miR-135a/NLRP37 axis in pancreatic cancer.

Yong Tang1, Guojun Cao1, Gang Zhao2, Chunyou Wang2, Qi Qin3.   

Abstract

Background It is well-known that long-chain non-coding RNA (LncRNA) plays an important role in the development of tumor. DANCR, which is one crucial part of the lncRNA family, has been shown to be involved in the invasion of various tumors. However, its molecular mechanism in pancreatic cancer remains unknown. Methods qRT-PCR was used to detect the expression of DANCR, miR-135a mRNA in pancreatic cancer tissues or cells. E-cadherin and NLRP3 protein levels were measured by Western Blot. CCK-8, cell scratch, and transwell assays were applied to detect the proliferation and invasion of pancreatic cancer cells. Bioinformatical analysis and luciferase assay were performed to explore the relationship among DANCR, miR-135a and NLRP3. Results In pancreatic cancer, DANCR was up-regulated while miR-135a was down-regulated. The over-expression of DANCR promoted the proliferation and invasion of pancreatic cancer cells. A negative relationship was found between DANCR and miR-135a expression. Moreover, we found that miR-135a reversed the effects of DANCR in the promoting of pancreatic cancer cells, which was achieved by regulating the downstream protein of NLRP3. The correlations among DANCR, miR-135a and NLRP3 were confirmed in animal experiments. Conclusion DANCR promoted proliferation and invasion through the regulating of miR-135a / NLRP3 axis in pancreatic cancer cell. Our results suggest that DANCR may be a potential target for the therapy of pancreatic cancer.

Entities:  

Keywords:  DANCR; Long-chain non-coding RNAs; Pancreatic cancer; miR-135a / NLRP3

Mesh:

Substances:

Year:  2019        PMID: 31267381     DOI: 10.1007/s10637-019-00798-0

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  12 in total

1.  Long non‑coding RNA HCG11 suppresses the malignant phenotype of non‑small cell lung cancer cells by targeting a miR‑875/SATB2 axis.

Authors:  Zhou Su; Mi Chen; Ruilin Ding; Lian Shui; Qingmei Zhao; Wenjuan Luo
Journal:  Mol Med Rep       Date:  2021-06-03       Impact factor: 2.952

2.  Roles of DANCR/microRNA-518a-3p/MDMA ceRNA network in the growth and malignant behaviors of colon cancer cells.

Authors:  Yi Sun; Bin Cao; Jingzhen Zhou
Journal:  BMC Cancer       Date:  2020-05-18       Impact factor: 4.430

Review 3.  MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy.

Authors:  Zhe Cao; Jiangdong Qiu; Gang Yang; Yueze Liu; Wenhao Luo; Lei You; Lianfang Zheng; Taiping Zhang
Journal:  Cancer Biol Med       Date:  2020-08-15       Impact factor: 4.248

Review 4.  Mechanistic role of DANCR in the choreography of signaling pathways in different cancers: Spotlight on regulation of Wnt/β-catenin and JAK/STAT pathways by oncogenic long non-coding RNA.

Authors:  Ammad Ahmad Farooqi; Auyezova Ardak Mukhanbetzhanovna; Seher Yilmaz; Lazzat Karasholakova; Ishmuratova Margarita Yulaevna
Journal:  Noncoding RNA Res       Date:  2021-01-13

Review 5.  Emerging Role of LncRNA Regulation for NLRP3 Inflammasome in Diabetes Complications.

Authors:  Xiaolin Lu; Qihong Tan; Jianyong Ma; Jing Zhang; Peng Yu
Journal:  Front Cell Dev Biol       Date:  2022-01-12

Review 6.  Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling Axis.

Authors:  Balamayooran Theivanthiran; Tarek Haykal; Linda Cao; Alisha Holtzhausen; Michael Plebanek; Nicholas C DeVito; Brent A Hanks
Journal:  Cancers (Basel)       Date:  2021-09-23       Impact factor: 6.639

7.  Identification of EMT-Related lncRNAs as Potential Prognostic Biomarkers and Therapeutic Targets for Pancreatic Adenocarcinoma.

Authors:  Yanyao Deng; Hai Hu; Le Xiao; Ting Cai; Wenzhe Gao; Hongwei Zhu; Shuai Wang; Jixing Liu
Journal:  J Oncol       Date:  2022-04-11       Impact factor: 4.501

8.  miR‑135a‑5p inhibits tumor invasion by targeting ANGPT2 in gallbladder cancer.

Authors:  Haiyan Diao; Xing Xu; Bin Zhao; Guanghua Yang
Journal:  Mol Med Rep       Date:  2021-05-26       Impact factor: 2.952

Review 9.  Long noncoding RNAs: role and contribution in pancreatic cancer.

Authors:  K T Ramya Devi; Dharshene Karthik; TharunSelvam Mahendran; M K Jaganathan; Sanjana Prakash Hemdev
Journal:  Transcription       Date:  2021-05-26

Review 10.  Long Non-coding RNA DANCR as an Emerging Therapeutic Target in Human Cancers.

Authors:  Shi-Jia Jin; Ming-Zhu Jin; Bai-Rong Xia; Wei-Lin Jin
Journal:  Front Oncol       Date:  2019-11-15       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.